- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01795989
Use of Specially Designed Pediatric MR Coils on Clinical Scanners
September 11, 2020 updated by: Children's Hospital Medical Center, Cincinnati
Novel Coils for Pediatric Musculoskeletal MRI
The purpose of this research study is to test the use of new Magnetic Resonance Imaging (MRI) coils.
An MRI takes pictures of body parts using a large magnet and a computer.
A coil is the part of the MRI system that collects data to make the MR images.
The investigators have designed, developed, and built two child-sized coils to use when imaging elbows, wrists, knees, and ankles.
These new coils will be better suited to fit infants through teenagers rather than the conventional coils used which were created for adults These MRI coils have not been approved by the US Food and Drug Administration (FDA) and are considered investigational devices.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The safety and the clinical efficacy/equivalence of two pediatric 1.5T coils will be evaluated/demonstrated in two phases.
Patient safety and image quality will be evaluated/demonstrated in Phase One by collecting images on healthy participants using a combination of the existing commercially available coils and the new coils.
Clinical efficacy/equivalence will be evaluated/demonstrated in Phase Two by collecting standard MRI exams in pediatric patients.
In Phase Two, the imaging data for a given patient will be collected by one of the two following scenarios : 1) the clinically ordered exams will be completed using a combination of the existing commercially available coils and new coil, with the images from each directly compared, or 2) the clinically ordered scans will be collected using one of the new coils and the images compared to historical de-identified MR exam, age and gender matched patient data (which were acquired using the existing commercially available coils).
Results of Phase One will be reported to the IRB.
Phase Two will not begin until the IRB has reviewed the results of Phase One and approved the commencement of Phase Two.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy volunteers and pediatric patients seen clinically in Radiology for a standard of care musculoskeletal (MSK) exam
Description
Inclusion Criteria:
Healthy Participants:
- Male or female
- Age: Old enough to participate in an MR study without sedation (typically greater than 5-6 years old)
Pediatric Patients:
- Male or female
- Sent for elbow MR or superficial/small parts musculoskeletal MR imaging.
- Age: any age
Exclusion Criteria:
- Female participants who are pregnant or lactating (verbal pregnancy screens will be given for all females of child bearing potential prior to the MRI).
- Subjects with standard contraindications to MRI.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy Volunteers
Research only musculoskeletal (MSK) MRI for healthy volunteers.
|
Pediatric coil for musculoskeletal imaging at 1.5 Tesla for pediatric patients and healthy participants.
|
Clinical Efficacy
Clinically indicated musculoskeletal (MSK) MRI with sequences obtained using this pediatric elbow coil.
|
Pediatric coil for musculoskeletal imaging at 1.5 Tesla for pediatric patients and healthy participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with adverse events as measured by heating and comfort participant response.
Time Frame: Day 1
|
Each participant will be monitored for adverse events during the MRI scan
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI Image Quality
Time Frame: Up to 3 weeks post MRI participant scan
|
The following measures will be individually evaluated on 3-point scale: Overall image quality, Image uniformity overall, and Signal to Noise.
|
Up to 3 weeks post MRI participant scan
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kathleen Emery, M.D., Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 18, 2011
Primary Completion (Actual)
December 29, 2014
Study Completion (Actual)
October 4, 2016
Study Registration Dates
First Submitted
July 3, 2012
First Submitted That Met QC Criteria
February 19, 2013
First Posted (Estimate)
February 21, 2013
Study Record Updates
Last Update Posted (Actual)
September 16, 2020
Last Update Submitted That Met QC Criteria
September 11, 2020
Last Verified
September 1, 2020
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on 1.5T MRI Elbow Coil
-
Hofmann, Bernd, M.D.Completed
-
Mayo ClinicNational Institute on Aging (NIA)Completed
-
Turku University HospitalUnknownFacial Asymmetry | Jaw DeformityFinland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingThoracic Neoplasms | Thoracic Cancer | Thoracic Diseases | Spine Metastases | Spine Disease | Spine CancerUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Boston Children's HospitalMassachusetts General Hospital; Massachusetts Institute of TechnologyRecruiting
-
GE HealthcareTerminatedTraumatic Brain Injury | Mild Traumatic Brain InjuryUnited States
-
Georgetown UniversityBaxter Healthcare CorporationTerminated
-
National Institute of Mental Health (NIMH)RecruitingUnipolar DepressionUnited States